Rhonda joined Foresite Capital in 2016, bringing more than 25 years of healthcare industry experience. She is a member of the investment team and contributes to due diligence and evaluation of companies.
Rhonda’s expertise in drug development ranges across translational medicine, clinical pharmacology, business development and outcomes research. Additionally, she has had 5 years of executive-level experience in the Managed Care industry.
Rhonda joined Foresite Capital after a 10-year career at Merck Research Laboratories, where she was a vice president. During her tenure at Merck she was on the senior team that established several departments, including: experimental medicine, regional deals and business development, emerging markets research and development, and health economics / outcomes research.
After graduating from Boston University, Rhonda completed her internship and residency in Internal Medicine at the Boston Veterans Administration Hospital, Boston, MA. Rhonda later completed a fellowship in Clinical Pharmacology and a Clinical Investigator Training Program at Tufts/Harvard-MIT Division of Health Sciences and Technology. Rhonda is a Diplomate in the American Board of Internal Medicine and the American Board of Clinical Pharmacology and maintains an active Medical License in the Commonwealth of Massachusetts.